Clinical Trial Update: 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in first- or second-line metastatic breast cancer patients previously treated with Avastin (bevacizumab). Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-16